Designed for PD-1, the tumor-infiltrating lymphocytes (TILs) were scored
Designed for PD-1, the tumor-infiltrating lymphocytes (TILs) were scored. O(6)-methylguanine-methyltransferase, and ribonucleotide reductase M1 (RRM1) was identified in 56%, 59%, 71%, and 58% of cases, respectively. Other illogisme included overexpression…